NeuraClick is a preclinical-stage biopharmaceutical company focused on developing novel first-in-class or best-in-class neuropeptide therapeutics for the treatment of major neurological and neuroendocrine disorders.
We apply “hydrocarbon-stapling or click-chemistry” technology to our body’s natural neuropeptides to make better therapeutics that are more potent, easy to penetrate across the blood-brain barrier, and devoid of major side effects compared to existing drugs on the market.
We explore the body’s natural neuropeptides with demonstrated biology and established safety profiles to minimize development risk.
Driving innovation in mental health therapeutics
Leveraging stapled peptide chemistry technology to accelerate drug discovery, reposition existing molecules with improved pharmacokinetic profiles and enhanced cellular uptake, and improve drug efficacy outcomes in a shorter time.
Accelerating faster clinical onset
Our approach is disruptive to today’s trial-and-error approach to treating neuropsychiatric conditions. Our team leverages deep expertise in neuroscience and stapling chemistry technology to offer faster and longer-lasting treatment effects for mental health and associated metabolic diseases.
OUR MISSION IS TO TRANSFORM
Our mission is to develop highly effective, safer, and affordable medicines to serve patients by harnessing the potential of the best of biology and technology to fight the world's most debilitating diseases.
OUR VISION IS TO MAKE IT HAPPEN
Our vision is to deliver breakthrough, innovative medicines that meaningfully improve patients’ lives and address their substantial unmet medical needs.
With deep compassion and a strong sense of urgency, we operate across all functions with exemplary moral and ethical responsibility, unwavering accountability, and undying commitment toward our patients, partners, and stakeholders.